Biogen (BIIB) Shares Fall as Guidance Comes In Below Consensus, Analyst Says Focus Remains on Aduhelm Coverage

Go back to Biogen (BIIB) Shares Fall as Guidance Comes In Below Consensus, Analyst Says Focus Remains on Aduhelm Coverage
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 199.71 --0 (-0%)
Previous Close $199.71    52 Week High $333.65 
Open $199.71    52 Week Low $223.02 
Day High $199.71    P/E 25.57 
Day Low $199.71    EPS $7.81 
Volume 2,289